FDA Inspection
Avista Pharma Solutions, Inc. dba CambrexFDA Inspection 1067530 - Avista Pharma Solutions, Inc. dba Cambrex - September 05, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Avista Pharma Solutions, Inc. dba Cambrex, with an inspection on September 5, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · d175dd6d-7561-482d-b246-920920a41ec5